Abstract
Proceedings of an Almirall-sponsored satellite symposium held at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Berlin, Germany, 10 October 2018.
Keywords:
THC:CBD oromucosal spray; multiple sclerosis spasticity treatment; observational studies; randomized controlled trials.
MeSH terms
-
Administration, Mucosal
-
Cannabidiol / administration & dosage
-
Cannabidiol / pharmacology*
-
Cannabinoid Receptor Modulators / administration & dosage
-
Cannabinoid Receptor Modulators / pharmacology*
-
Congresses as Topic*
-
Dronabinol / administration & dosage
-
Dronabinol / pharmacology*
-
Drug Combinations
-
Humans
-
Multiple Sclerosis / complications
-
Multiple Sclerosis / drug therapy*
-
Muscle Spasticity / drug therapy*
-
Muscle Spasticity / etiology
-
Observational Studies as Topic*
-
Oral Sprays
-
Randomized Controlled Trials as Topic*
-
Societies, Medical
Substances
-
Cannabinoid Receptor Modulators
-
Drug Combinations
-
Oral Sprays
-
Cannabidiol
-
Dronabinol
-
nabiximols